Natural killing activity in patients with spontaneous regression of malignant lymphoma

Journal of Clinical Immunology

Volumn 16, Issue 6, 1996, Pages 334-339

  Ono, Kazutoshi ^a   Kikuchi, Masako ^a   Funai, Noriko ^a   Matsuzaki, Miwako ^a   Shimamoto, Yoshinori ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Adult T cell leukemia lymphoma; Malignant lymphoma; Natural killing activity; Non Hodgkin's lymphoma; Spontaneous regression

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGRESSION; CASE REPORT; FEMALE; HUMAN; HUMAN CELL; LYMPHOMA; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0029851355     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01541669     Document Type: Article

References (41)

1. Gattiker HH, Wiltshaw E, Galton DAG: Spontaneous regression in non-Hodgkin's lymphoma. Cancer 45:2627-2632, 1980
2. Krikorian JG, Portlock CS, Cooney DP, Rosenberg SA: Spontaneous regression of non-Hodgkin's lymphoma: A report of nine cases. Cancer 46:2093-2099, 1980
3. Wiernik PH: Spontaneous regression of hematologic cancers. Natl Cancer Inst Monogr 44:35-38, 1976
4. Horning SJ, Rosenberg SA: The natural history of initially untreated low-grade non-Hodgkin's lymphoma. N Engl J Med 311:1471-1475, 1984
5. Grem JL, Hafez GR, Brandenburg JH, Carbone PP: Spontaneous remission in diffuse large cell lymphoma. Cancer 57:2042-2044, 1986
6. Strauchen JA, Moran C, Goldsmith M, Greenberg M: Spontaneous regression of gastric lymphoma. Cancer 60:1872-1875, 1987
7. Shigematsu A, Iida M, Lien GS, Imamura T, Okada M, Fuchigami T, Fujishima M, Itoh H, Iwashita A: Spontaneous regression of primary malignant lymphoma of the stomach in two nontreated Japanese. J Clin Gastroenterol 11:511-517, 1989
8. Ziegler JL: Spontaneous remission in Burkitt's lymphoma. Natl Cancer Inst Monogr 44:61-65, 1976
9. Poppema S, Postma L, Brinker M, Jong B: Spontaneous regression of a small non-cleaved cell malignant lymphoma (non-Burkitt's lymphoblastic lymphoma): Morphologic, immunohistochemical, and immunoglobulin gene analysis. Cancer 62:791-794, 1988
10. Kimura I, Tsubota T, Hayashi K, Ohnoshi T: Spontaneous complete remission in adult T-cell leukemia: A case report. Jpn J Clin Oncol 13 (Suppl 2): 231-236, 1983
11. Schnitzer B, Lovett EJ III, Kahn LE: Adult T-cell leukemia with spontaneous remission. Lancet 2:1030, 1983 (letter)
12. Kawano F, Tsuda H, Yamaguchi K, Nishimura H, Sanada I, Matsuzaki K: Unusual clinical courses of adult T-cell leukemia in siblings. Cancer 54:131-134, 1984
13. Tagawa S, Konoshi I, Tokumine Y, Kuratsune H, Machii T, Kitani T: Phenotypical heterogeneity of Japanese adult T-cell leukemia. Scand J Haematol 32:306-312, 1984
14. Mattock C, Anderson NA, Sheldon CD, Rustin MH, Hoffbrand BI: Spontaneous remission and relapse in adult T-cell lymphoma/ leukemia associated with HTLV-I. Br Med J 292:1171-1172, 1986 (letter)
15. Weintraub LR: Lymphosarcoma: Remission associated with viral hepatitis. JAMA 210:1590-1591, 1969
16. Zygiert Z: Hodgkin's disease: Remissions after measles. Lancet 1:953, 1971 (letter)
17. Bluming AZ, Ziegler JL: Regression of Burkitt's lymphoma in association with measles infection. Lancet 2:105-106, 1971 (letter)
18. Taqi AM, Abdurrahman MB, Yakubu AM, Fleming AF: Regression of Hodgkin's disease after measles. Lancet 1:1112, 1981 (letter)
19. McClain K, Warkentin P, Kay N: Spontaneous remission of Burkitt's lymphoma associated with herpes zoster infection. Am J Pediatr Hematol Oncol 7:9-14, 1985
20. Ono K, Shimamoto Y, Nishimura J, Yamaguchi M, Nawata H: A new analysis of natural killing activity and the role of monocytes in normal subjects. J Clin Lab Immunol 30:175-181, 1989
21. Bancroft GJ, Shellam GR, Chalmer JE: Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: Correlation with patterns of resistance. J Immunol 126:988-994, 1981
22. Ennis FA, Meager A, Beare AS, Hua Q, Riley D, Schwarz Z, Schild GC, Rook AH: Interferon induction and increased natural killer-cell activity in influenza infections in man. Lancet 2:891-893, 1981
23. Rygaard J, Povlsen CO: The mouse mutant nude does not develop spontaneous tumors - an argument against immunological surveillance. Acta Pathol Microbiol Scand B 82:99-106, 1974
24. Gorelik E, Wiltrout RH, Okumura K, Habu S, Herberman RB: Role of NK cells in the control of metastatic spread and growth of tumor cells in mice. Int J Cancer 30:107-112, 1982
25. Barlozzari T, Leonhart J, Wiltrout RH, Herberman RB, Reynolds CW: Direct evidence for the role of LGL in the inhibition of experimental tumor metastasis. J Immunol 134:2783-2789, 1985
26. Pross HF, Baines MG, Rubin P, Shragge P, Patterson MS: Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol 1:51-63, 1981
27. The Non-Hodgkin's Lymphoma Pathologic Classification Project: National Cancer Institute sponsored study of classification of non-Hodgkin's lymphoma: Summary and description of a working formulation for clinical usage. Cancer 49:2112-2135, 1982
28. Gupta S, Fernandes G: Spontaneous and antibody-dependent cellular cytotoxicity by lymphocyte subpopulations in peripheral blood and spleen from adult untreated patients with Hodgkin's disease. Clin Exp Immunol 45:205-214, 1981
29. Tursz T, Dokhelar MC, Lipinski M, Amiel JL: Low natural killer cell activity in patients with malignant lymphoma. Cancer 50: 2333-2335, 1982
30. Hawrylowicz CM, Rees RC, Hancock BW, Potter CW: Depressed spontaneous natural killing and interferon augmentation in patients with malignant lymphoma. Eur J Cancer Clin Oncol 18:1081-1088, 1982
31. Levy S, Tempe JL, Aleksijevic A, Giron C, Oberling F, Mayer S, Lang LM: Depressed NK cell activity of peripheral blood mononuclear cells in untreated Hodgkin's disease: Enhancing effect of interferon in vitro. Scand J Haematol 33:386-390, 1984
32. Frydecka I: Natural killer cell activity during the course of disease in patients with Hodgkin's disease. Cancer 56:2799-2803, 1985
33. Mehta B, Advani S, Nadkarni J: Non-Hodgkin's Lymphoma: Natural cell-mediated cytotoxicity correlated with histological classification and prognosis. Oncology 46:323-325, 1989
34. Rajaram N, Tatake RJ, Advani SH, Gangal SG: Natural killer and lymphokine activated killer cell functions in Hodgkin's disease. Br J Cancer 62:205-208, 1990
35. Caldera LH, Leon-Ponte M, Acquatella G, Bianco NE, Blanca I: Bone marrow and peripheral blood natural killer cell activity in lymphomas. Its response to IL-2. Clin Exp Immunol 88:143-148, 1992
36. Ono K, Imazono Y, Misawa T, Nishimura J, Nawata H: Natural killing activity is associated with progression of gastic cancer. J Clin Immunol 15:210-214, 1995
37. Ono K, Yamanaga Y, Yamamoto K, Koga S, Nishimura J, Nawata H: Natural killing activities in chronic liver diseases and hepatocellular carcinoma. J Clin Immunol 16:41-45, 1996
38. Ljunggren HG, Karre K: Experimental strategies and interpretations in the analysis of changes in MHC gene expression during tumour progression. Opposing influences of T cell and natural killer mediated resistance? J Immunogenet 13:141-151, 1986
39. Correa I, Corral L, Raulet DH: Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells. Eur J Immunol 24:1323-1331, 1994
40. Trinchieri G: Recognition of major histocompatibility complex class I antigens by natural killer cells. J Exp Med 180:417-421, 1994
41. Oshimi K, Oshimi Y, Yamada O, Mizoguchi H: Lysis of lymphoma cells by autologous and allogenic natural killer cells. Blood 65:638-643, 1985